CureZone   Log On   Join
Re: FermaVir to Present Portfolio of Antiviral Drug Candidates at BIO 2006 Annual Conference
 
blackcat Views: 1,647
Published: 15 years ago
 
This is a reply to # 373,382

Re: FermaVir to Present Portfolio of Antiviral Drug Candidates at BIO 2006 Annual Conference


Again its part of a "portfolio" of anti-viral drugs they will be releasing...

"CF-1743 is among a portfolio of FermaVir's proprietary candidates planned for development to treat a family of viral diseases caused by herpes viruses."

So ts not just herpes zoster. Valtrex is subscribed for herpes zoster (shingles)...so can FermaVir's new drug CF-1743 be subscribed for HSV-2 since its 10,000 times more potent than currently approved drug treatments (as they claim)?
 
Printer-friendly version of this page Email this message to a friend
Alert Moderators
Report Spam or bad message  Alert Moderators on This GOOD Message

This Forum message belongs to a larger discussion thread. See the complete thread below. You can reply to this message!


 

Donate to CureZone


CureZone Newsletter is distributed in partnership with https://www.netatlantic.com


Contact Us - Advertise - Stats

Copyright 1999 - 2021  www.curezone.com

0.594 sec, (1)